You’re good to go
Taffix is a scientifically proven nasal spray that creates a hostile microenvironment in the nose where up to 97% of airborne viruses can’t survive.
Taffix does not replace use of masks and all other measures recommended by health authorities
Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of Taffix™ Intranasal Antiviral Protection in Super Spread Event
Tel Aviv , Israel, October 13, 2020
VIEW FULL PR
The Taffix™ (Powder) Spray Device is indicated for use against allergens and viruses within the nasal cavity.
"We were impressed by the ability of Taffix™ to effectively reduce the amount of live virus. This innovative approach could provide a valuable protective measure that would help reduce the spread of the virus and complement worldwide efforts to find a drug or a vaccine”.
- Barbara Mann
Ph.D. Associate Professor, Medicine: Infectious Diseases and International Health at the University of Virginia
University of Virginia Study
In a series of laboratory in vitro studies mimicking the nasal cavity that were performed at the University of Virginia with cells cultures, Taffix™ gel was found to be highly effective and consistently reduced infection* by 99.9%.
The gel layer produced by Taffix™ powder after administration of a clinical equivalent amount, effectively blocked the infections.
How It Works
Taffix’s creates a hostile microenvironment in the nose where up to 97% of airborne viruses can’t survive.
Protect the nose
Your nose is the primary route of infection for all airborne viruses. It has a pH of 6.5 which viruses just love.
The spray creates an ultra-thin gel in your nasal cavity that provides protection for 5 hours.
The ultra-thin gel lowers the nasal cavity’s pH to 3.5, where up to 97% of viruses are rendered ineffective.